JP2010526776A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010526776A5 JP2010526776A5 JP2010506268A JP2010506268A JP2010526776A5 JP 2010526776 A5 JP2010526776 A5 JP 2010526776A5 JP 2010506268 A JP2010506268 A JP 2010506268A JP 2010506268 A JP2010506268 A JP 2010506268A JP 2010526776 A5 JP2010526776 A5 JP 2010526776A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- peptide
- sequence
- composition
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 108
- 206010028980 Neoplasm Diseases 0.000 claims description 36
- 201000011510 cancer Diseases 0.000 claims description 36
- 239000008194 pharmaceutical composition Substances 0.000 claims description 28
- 239000000203 mixture Substances 0.000 claims description 24
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 17
- 101710184277 Insulin-like growth factor 1 receptor Proteins 0.000 claims description 17
- 239000003814 drug Substances 0.000 claims description 14
- 125000003275 alpha amino acid group Chemical group 0.000 claims description 13
- 230000033115 angiogenesis Effects 0.000 claims description 13
- 101000659545 Homo sapiens U5 small nuclear ribonucleoprotein 200 kDa helicase Proteins 0.000 claims description 10
- 241000124008 Mammalia Species 0.000 claims description 10
- 101000751147 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L19-A Proteins 0.000 claims description 10
- 101000751149 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) 60S ribosomal protein L19-B Proteins 0.000 claims description 10
- 102100036230 U5 small nuclear ribonucleoprotein 200 kDa helicase Human genes 0.000 claims description 10
- 229940079593 drug Drugs 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims description 4
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims description 4
- 229940083963 Peptide antagonist Drugs 0.000 claims description 2
- 238000000034 method Methods 0.000 description 15
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US92598207P | 2007-04-24 | 2007-04-24 | |
| PCT/US2008/005316 WO2008133961A2 (en) | 2007-04-24 | 2008-04-23 | Igf-1r binding proteins and antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010526776A JP2010526776A (ja) | 2010-08-05 |
| JP2010526776A5 true JP2010526776A5 (enExample) | 2011-06-16 |
Family
ID=39731759
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010506268A Withdrawn JP2010526776A (ja) | 2007-04-24 | 2008-04-23 | Ｉｇｆ−１ｒ結合タンパク質およびアンタゴニスト |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20110039779A1 (enExample) |
| EP (1) | EP2152742B1 (enExample) |
| JP (1) | JP2010526776A (enExample) |
| CN (1) | CN101802001A (enExample) |
| AU (1) | AU2008244496A1 (enExample) |
| CA (1) | CA2685115A1 (enExample) |
| WO (1) | WO2008133961A2 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023130146A2 (en) * | 2022-01-03 | 2023-07-06 | Nighthawk Biosciences, Inc. | Cellular uptake peptide-therapeutic payload compositions and methods of use |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7173005B2 (en) | 1998-09-02 | 2007-02-06 | Antyra Inc. | Insulin and IGF-1 receptor agonists and antagonists |
| US6875741B2 (en) | 1998-09-02 | 2005-04-05 | Renuka Pillutla | Insulin and IGF-1 receptor agonists and antagonists |
| EP1383793B1 (en) | 2000-03-29 | 2011-10-19 | DGI BioTechnologies, L.L.C. | Insulin and igf-1 receptor agonists and antagonists |
-
2008
- 2008-04-23 WO PCT/US2008/005316 patent/WO2008133961A2/en not_active Ceased
- 2008-04-23 CN CN200880021811A patent/CN101802001A/zh active Pending
- 2008-04-23 US US12/597,482 patent/US20110039779A1/en not_active Abandoned
- 2008-04-23 JP JP2010506268A patent/JP2010526776A/ja not_active Withdrawn
- 2008-04-23 EP EP08743270A patent/EP2152742B1/en not_active Not-in-force
- 2008-04-23 AU AU2008244496A patent/AU2008244496A1/en not_active Abandoned
- 2008-04-23 CA CA002685115A patent/CA2685115A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW201018471A (en) | Multiple exon skipping compositions for DMD | |
| EP2173373B1 (en) | Soluble her2 and her3 splice variant proteins, splice-switching oligonucleotides, and their use in the treatment of disease | |
| JP7049262B2 (ja) | 結合組織成長因子を標的とするｒｎａ複合体を用いた特発性肺胞線維症の治療 | |
| JP2018512454A5 (enExample) | ||
| AU2025263913A1 (en) | Cell-Penetrating Peptides | |
| NZ591130A (en) | Compositions comprising a PD-1 antagonists and cyclophosphamide and methods of use thereof | |
| JP2010518079A5 (enExample) | ||
| WO2008022046B1 (en) | Dicer substrate rna peptide conjugates and methods for rna therapeutics | |
| AU2019319685B2 (en) | Cell-penetrating peptides | |
| JP2010538005A5 (enExample) | ||
| JP2023538422A5 (enExample) | ||
| JPWO2019156137A5 (enExample) | ||
| JP2022533358A5 (enExample) | ||
| JP2013523718A5 (enExample) | ||
| TW200526780A (en) | TNF antagonists and TNF inhibitors comprising the same as the active ingredient | |
| JP2020525462A5 (ja) | 改善された薬物送達のためのステープルされた又はステッチされたペプチドを含む化合物 | |
| CA2744339A1 (en) | Method for treating parkinson's disease | |
| JP2011505798A5 (enExample) | ||
| CN111601815A (zh) | 靶向细胞中c-Myc的嵌合分子 | |
| JP2015533372A5 (enExample) | ||
| EP3802545A1 (en) | Organic compounds | |
| JP2012504941A5 (enExample) | ||
| JP7412576B2 (ja) | 腎がんの相乗的治療におけるペグインターフェロンおよびプロトオンコジーン産物標的阻害剤の適用 | |
| WO2022243932A1 (en) | Polypeptides related to hmgb1 useful for promoting tissue regeneration, compositions comprising same, and uses thereof | |
| JP2018512844A5 (enExample) |